+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Renal outcome of immunoglobulin a nephropathy with mild proteinuria

Renal outcome of immunoglobulin a nephropathy with mild proteinuria

Acta Medica Nagasakiensia 48(1-2): 39-43

We determined the natural history of immunoglobulin A nephropathy (IgAN) among patients who presented with mild proteinuria (0.2 to 0.4 g/day), and factors associated with development of adverse clinical events, defined as proteinuria gtoreq 1.0 g/day, blood pressure > 130/80 mmHg, serum creatinine gtoreq 1.4 mg/dl. We did analyzed data from 27 patients (mean age 30 +/- 12 years) with IgAN accompanied by mild proteinuria between 1990 and 1998.

(PDF emailed within 1 workday: $29.90)

Accession: 012506508

Download citation: RISBibTeXText

Related references

Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria. Clinical Nephrology 60(2): 85-89, 2003

Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria. Clinical and Experimental Nephrology 19(5): 815-821, 2016

Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria. Journal of Nephropathology 5(2): 72-78, 2016

Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial. Korean Journal of Internal Medicine 31(2): 335-343, 2016

Clinical study of reflux nephropathy. I. Outcome of renal function in VUR patients with proteinuria. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 76(10): 1516-1523, 1985

Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria. Bmc Nephrology 15(): 107-107, 2015

Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria. Archives of Medical Science 11(2): 332-339, 2015

Reduction of proteinuria by therapeutic intervention improves the renal outcome of elderly patients with IgA nephropathy. Clinical and Experimental Nephrology 20(6): 910-917, 2016

Immunoglobulin a nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists. American Journal of Medicine 110(6): 499-500, 2001

Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features. Internal Medicine 40(8): 697-702, 2001

Long term outcome of renal allografts in patients with immunoglobulin A nephropathy. Medical Journal of Malaysia 62(2): 109-113, 2008

Effect of baseline proteinuria and change in proteinuria with treatment on the risk of renal endpoints in the irbesartan diabetic nephropathy trial. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 7A, September, 2002

Urine TGF-beta1 levels predict adverse renal outcome and predict increasing proteinuria in patients with IgA nephropathy. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 60A, September, 2000

Mild immunoglobulin A nephropathy in a patient with a marked increase in serum immunoglobulin A. Pediatrics International 46(3): 371-373, 2004

Effects of Hydroxychloroquine on Proteinuria in Immunoglobulin A Nephropathy. American Journal of Nephrology 47(3): 145-152, 2018